JENKEM TECHNOLOGY CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 80.16 CNY | -5.47% |
|
+0.14% | -24.66% |
| Apr. 29 | Jenkem Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 09 | Shanghai stocks end higher, investors cautious ahead US inflation and China data | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Jenkem Technology Co Ltd is a company mainly engaged in research and development, production and sales of polyethylene glycol and its active derivatives. The Company's primary products are medical polyethylene glycol and its active derivatives, which are used in research, development and production of drugs and medial devices, scientific research institutions and other fields. The Company is also involved in providing technical services, including patent and non-patent technology licensing services, as well as research and development services.
Sector
Specialty Chemicals
Calendar
2024-08-21
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
80.16
CNY
Average target price
103
CNY
Spread / Average Target
+28.49%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -24.66% | 712M | |
| 0.00% | 20.13B | |
| -11.77% | 5.39B | |
| +14.74% | 1.46B | |
| -2.36% | 1.14B | |
| +21.20% | 967M | |
| -6.95% | 756M | |
| -9.29% | 303M | |
| -8.16% | 267M | |
| -1.05% | 261M |
- Stock Market
- Equities
- 688356 Stock
- News Jenkem Technology Co., Ltd.
- Jenkem Technology Enrolls First Subject for Trial of Injectable Skin Solution